BRCA2 and cancer: In this study, we analyzed publicly available data from the ClinVar database and found remarkably few clinically significant discordances in the classifications of more than 2,000 variants in two well-characterized cancer risk genes, BRCA1 and BRCA2. The observation that all discordant variants were rare, although most rare variants remained concordant, suggests that roughly one of 500 patients would be expected to receive results that would significantly change clinical management from the various laboratories in this study.